Avelumab in Combination with Lorlatinib or Crizotinib in Patients with Previously Treated Advanced NSCLC: Phase 1b/2 Results from the JAVELIN Lung 101 Trial
JTO Clinical and Research Reports(2024)
Key words
Non-small cell lung cancer,Avelumab,Lorlati- nib,Crizotinib,Phase 1b/2
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined